Plain-English translation of NCT02012699 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Read our Pancreatic Cancer research guide →The Integrated Cancer Repository (iCaRe2) is a large research database being built at the University of Nebraska Medical Center. It collects tissue samples, blood, and other biological specimens along with medical records from cancer patients, people at high risk for cancer, and healthy volunteers. This information helps cancer researchers understand the disease better and develop new treatments.
Cancer researchers need access to real patient samples and medical data to study how different cancers develop and find better ways to treat them. By creating a shared database that multiple research centers can use, scientists can work together more effectively and learn from larger groups of patients.
You likely qualify if…
You likely don't qualify if…
If you join this study, you will be asked to donate biological samples such as blood, tissue, or urine, and to allow researchers access to your medical records. The study is ongoing and does not have a set time limit — you can participate as long as you are willing. There is no specific medication or treatment being tested; this is purely a data and sample collection effort to support cancer research.
AI-generated summary from trial data · Jul 7, 2026 · Not medical advice
United States